Grant Feeds

Subscribe to Grant Feeds feed
The documents in this feed originate from FederalRegister.gov which displays an unofficial web version of the daily Federal Register. The official electronic version in PDF format is also available as a link from the FederalRegister.gov website. For more information, please see https://www.federalregister.gov/reader-aids/policy/legal-status.
Updated: 29 min 33 sec ago

Alaska; Emergency and Related Determinations

Thu, 12/27/2018 - 23:00
This is a notice of the Presidential declaration of an emergency for the State of Alaska (FEMA-3410-EM), dated November 30, 2018, and related determinations.

California; Amendment No. 2 to Notice of a Major Disaster Declaration

Thu, 12/27/2018 - 23:00
This notice amends the notice of a major disaster declaration for the State of California (FEMA-4407-DR), dated November 12, 2018, and related determinations.

Alabama; Amendment No. 1 to Notice of a Major Disaster Declaration

Thu, 12/27/2018 - 23:00
This notice amends the notice of a major disaster declaration for the State of Alabama (FEMA-4406-DR), dated November 5, 2018, and related determinations.

Oil and Gas and Sulfur Operations in the Outer Continental Shelf-Request for Information Regarding Potential Impacts of Decommissioning-in-Place of Pipeline-Related Infrastructure in Deepwater

Thu, 12/27/2018 - 23:00
The Bureau of Safety and Environmental Enforcement (BSEE) is soliciting information and public comments regarding potential impacts (including impacts on future use of the Outer Continental Shelf (OCS)) related to decommissioning-in-place (DIP) of certain pipeline-related infrastructure in deepwater (i.e., depths of at least 600 feet) on the OCS. Responses to this Request for Information (RFI) will help identify technical, safety and environmental factors, as well as potential impacts to other uses of the OCS, that will inform BSEE's consideration of requests to allow DIP of such pipeline-related infrastructure in deepwater in lieu of decommissioning by removal. BSEE intends to make any written comments or other information submitted in response to this RFI publicly available on www.regulations.gov.

Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2019

Thu, 12/27/2018 - 23:00
This final order establishes the initial 2019 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.

National Vaccine Injury Compensation Program; List of Petitions Received

Thu, 12/27/2018 - 23:00
HRSA is publishing this notice of petitions received under the National Vaccine Injury Compensation Program (the Program), as required by the Public Health Service (PHS) Act, as amended. While the Secretary of HHS is named as the respondent in all proceedings brought by the filing of petitions for compensation under the Program, the United States Court of Federal Claims is charged by statute with responsibility for considering and acting upon the petitions.

Financial Crimes Enforcement Network; Bank Secrecy Act Advisory Group; Solicitation of Application for Membership

Thu, 12/27/2018 - 23:00
FinCEN is inviting the public to nominate financial institutions, trade groups, and non-federal regulators or law enforcement agencies for membership on the Bank Secrecy Act Advisory Group. New members will be selected for three-year membership terms.

Determination of Regulatory Review Period for Purposes of Patent Extension; XERMELO

Thu, 12/27/2018 - 23:00
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for XERMELO and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human drug product.

Certain LED Devices, LED Power Supplies, and Components Thereof Notice of Request for Submissions on the Public Interest

Thu, 12/27/2018 - 23:00
Notice is hereby given that the presiding administrative law judge (``ALJ'') has issued a recommended determination on remedy and bonding should a violation be found in the above-captioned investigation. The Commission is soliciting submissions on public interest issues raised by the recommended limited exclusion order against certain LED devices, LED power supplies, and components thereof, manufactured and imported by respondents Feit Electric Company, Inc. of Pico Rivera, California; Feit Electric Company, Inc. (China) of Xiamen, China; L G Sourcing, Inc. of North Wilkesboro, North Carolina; and Satco Products, Inc. of Brentwood, New York. This notice is soliciting comments from the public only. Parties are to file public interest submissions pursuant to 19 CFR 210.50(a)(4).

Crystalline Silicon Photovoltaic Cells, Whether or Not Assembled Into Modules, From the People's Republic of China: Preliminary Results of Antidumping Duty Administrative Review and Preliminary Determination of No Shipments; 2016-2017

Thu, 12/27/2018 - 23:00
The Department of Commerce (Commerce) preliminarily determines that producers and/or exporters subject to this administrative review made sales of subject merchandise at less than normal value. Interested parties are invited to comment on these preliminary results of review.

Determination of Regulatory Review Period for Purposes of Patent Extension; RYDAPT

Thu, 12/27/2018 - 23:00
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for RYDAPT and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human drug product.

Pages